NEUROCRINE BIOSCIENCES INC
NBIX
54 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Feb 13 9:37 PM | MATTHEW C ABERNETHY | Proposed Sale | 1,206 | $117.18 | $141.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:37 PM | KEVIN CHARLES GORMAN | Proposed Sale | 3,012 | $117.18 | $352.9K | — | View → |
| Feb 13, 2025 | Feb 13 9:37 PM | KYLE W GANO | Proposed Sale | 1,206 | $117.18 | $141.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:37 PM | JULIE SMITH COOKE | Proposed Sale | 755 | $117.18 | $88.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | ERIC S BENEVICH | Proposed Sale | 1,056 | $117.18 | $123.7K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | JUDE ONYIA | Proposed Sale | 1,447 | $117.18 | $169.6K | — | View → |
| Feb 13, 2025 | Feb 13 9:36 PM | INGRID DELAET | Proposed Sale | 755 | $117.18 | $88.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:35 PM | DAVID WARREN BOYER | Proposed Sale | 830 | $117.18 | $97.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:35 PM | DARIN LIPPOLDT | Proposed Sale | 1,086 | $117.18 | $127.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:35 PM | EIRY WYN ROBERTS | Proposed Sale | 604 | $117.18 | $70.8K | — | View → |
| Feb 13, 2025 | Feb 13 9:34 PM | EIRY ROBERTS | Proposed Sale | 1,114 | $117.18 | $130.5K | — | View → |
| Feb 13, 2025 | Feb 13 9:34 PM | DARIN LIPPOLDT | Proposed Sale | 1,098 | $117.18 | $128.7K | — | View → |
| Feb 13, 2025 | Feb 13 9:34 PM | ERIC BENEVICH | Proposed Sale | 1,098 | $117.18 | $128.7K | — | View → |
| Feb 13, 2025 | Feb 13 9:34 PM | JUDE ONYIA | Proposed Sale | 1,432 | $117.18 | $167.8K | — | View → |
| Feb 13, 2025 | Feb 13 9:33 PM | INGRID DELAET | Proposed Sale | 716 | $117.18 | $83.9K | — | View → |
| Feb 13, 2025 | Feb 13 9:33 PM | DAVID WARREN BOYER | Proposed Sale | 955 | $117.18 | $111.9K | — | View → |
| Feb 13, 2025 | Feb 13 9:33 PM | JULIE COOKE | Proposed Sale | 796 | $117.18 | $93.3K | — | View → |
| Feb 13, 2025 | Feb 13 9:32 PM | KYLE GANO | Proposed Sale | 1,352 | $117.18 | $158.4K | — | View → |
| Feb 13, 2025 | Feb 13 9:31 PM | Kevin Charles Gorman | Proposed Sale | 2,832 | $117.18 | $331.9K | — | View → |
| Feb 10, 2025 | Feb 10 9:33 PM | KYLE W GANO | Proposed Sale | 980 | $122.62 | $120.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026 | Feb 3 11:03 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 2,927 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:02 PM | Kevin Charles GormanDirector | Option Exercise | 5,142 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Darin LippoldtChief Legal Officer | Option Exercise | 2,373 | — | 0(D) | View → |
| Jan 31, 2026 | Feb 3 11:01 PM | Jude OnyiaChief Scientific Officer | Option Exercise | 238 | — | 0(D) | View → |
| Jan 16, 2026 | Jan 20 11:56 PM | Kyle GanoDirector, Chief Executive Officer | Option Exercise | 36,400 | $35.99 | 0(D) | View → |
← Previous
Page 4 of 4